Suchergebnisse - "Schvoerer, E"

PubPharm (69)

1

Somatic coliphages are conservative indicators of SARS-CoV-2 inactivation during heat and alkaline pH treatments

enthalten in: The Science of the total environment | 2021

von Varbanov, M. | Bertrand, I. | Philippot, S. | +8

2

Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey

enthalten in: The Journal of antimicrobial chemotherapy | 2021

von Marcelin, A. | Charpentier, C. | Bellecave, P. | +118

3

An Unexpected Effect of Maraviroc Could Make It a Future Treatment for Sarcoidosis

enthalten in: Journal of investigational allergology & clinical immunology | 2021

von Goehringer, F. | Tiotiu, A. | Schvoerer, E. | +2

4

Surveillance of HIV-1 primary infections in France from 2014 to 2016 : toward stable resistance, but higher diversity, clustering and virulence?

enthalten in: The Journal of antimicrobial chemotherapy | 2020

von Visseaux, B. | Assoumou, L. | Mahjoub, N. | +117

5

Transmission of hepatitis E virus by water : An issue still pending in industrialized countries

enthalten in: Water research | 2019

von Fenaux, H. | Chassaing, M. | Berger, S. | +3

6

Molecular features of Hepatitis E Virus circulation in environmental and human samples

enthalten in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2018

von Fenaux, H. | Chassaing, M. | Berger, S. | +7

7

Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2018

von Raymond, S. | Nicot, F. | Pallier, C. | +129

8

Characterization of hepatitis B virus surface antigen variability and impact on HBs antigen clearance under nucleos(t)ide analogue therapy

enthalten in: Journal of viral hepatitis | 2016

von Velay, A. | Jeulin, H. | Eschlimann, M. | +11

9

Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir : a French national study of raltegravir-experienced HIV-1-infected patients

enthalten in: The Journal of antimicrobial chemotherapy | 2015

von Fourati, S. | Charpentier, C. | Amiel, C. | +120

10

Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma

enthalten in: The Journal of antimicrobial chemotherapy | 2015

von Soulie, C. | Descamps, D. | Grudé, M. | +101

1
2
3
4
5
6
7
Nächster »
[7]